What happens when you CRISPR people?
Few questions generated more contentious discussion in biotech in the mid-2010s, as researchers and executives debated the relative merits of preclinical studies that pointed both to the new gene-editing tool’s potential to cure numerous diseases and its potential to cause unintended genetic damage.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
